Imagenebio Inc (IMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | -18,205 | -11,983 | -6,945 |
| Depreciation Amortization | 225 | 617 | 74 |
| Accounts payable and accrued liabilities | 89 | -138 | 155 |
| Other Working Capital | -9,136 | -6,949 | -3,609 |
| Other Operating Activity | 1,771 | 867 | 451 |
| Operating Cash Flow | $-25,256 | $-17,586 | $-9,874 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -116 | -116 | -117 |
| Investing Cash Flow | $-116 | $-116 | $-117 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 21 | 21 | 21 |
| Financing Cash Flow | $21 | $21 | $21 |
| Beginning Cash Position | 82,083 | 82,083 | 82,083 |
| End Cash Position | 56,732 | 64,402 | 72,113 |
| Net Cash Flow | $-25,351 | $-17,681 | $-9,970 |
| Free Cash Flow | |||
| Operating Cash Flow | -25,256 | -17,586 | -9,874 |
| Capital Expenditure | -116 | -116 | -117 |
| Free Cash Flow | -25,372 | -17,702 | -9,991 |